Wednesday 14 October 2026
Export CVS’s income statement to Excel — free account
CVS Health Corporation
CVS Healthcare Healthcare Plans
CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024. In the quarter to June 2026, revenue grew 7.26%, EPS grew 187.7%, free cash flow grew 338.3% and total debt fell 7.64%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.
87.65
0.09
−0.10%
Follow CVS
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
0.63% | 2.34% | 3.79% | 6.21% | |
Piotroski F-Score |
7 | 7 | 5 | 6 | |
| 0.18% | 0.70% | 1.15% | 1.91% | ||
ROIC |
2.41% | 2.25% | 2.89% | 4.07% | |
Return on Tangible Assets |
(17.07%) | (197.54%) | 202.49% | 331.98% | |
Average Days of Receivables |
40.62 | 36.11 | 36.68 | 35.45 | |
Free Cash Flow per Share |
4.96 | 6.16 | 5.81 | 9.19 | |
Free Cash Flow |
6,293.00 | 7,807.00 | 7,394.00 | 11,758.00 | |
Capital Expenditures |
(2,816.00) | (2,832.00) | (2,938.00) | (3,022.00) | |
| Other line items | |||||
Cash ROIC |
4.19% | 5.19% | 4.85% | 7.57% | |
Accounts Receivable Turnover |
9.85 | 10.55 | 10.12 | 10.25 | |
Accounts Payable Turnover |
12.99 | 13.19 | 13.48 | 13.39 | |
Inventory Turnover |
11.87 | 11.84 | 12.83 | 13.14 | |
Average Days of Payables |
29.83 | 29.11 | 27.38 | 27.19 | |
Days of Inventory on Hand |
31.84 | 31.76 | 28.76 | 27.92 | |
Tax Rate |
(0.85) | (0.19) | (0.16) | (0.16) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.14% | 0.13% | 0.17% | 0.17% | |
Interest Coverage |
1.59 | 1.49 | 1.92 | 2.67 | |
Operating CF/Net income |
19.42 | 6.02 | 3.52 | 3.02 | |
Depreciation/Fixed assets |
0.80 | 0.79 | 0.79 | 0.78 | |
Capex/Depreciation |
(0.27) | (0.27) | (0.29) | (0.29) | |
Revenue per Share |
310.55 | 317.34 | 320.43 | 324.54 | |
Operating CF per Share |
7.18 | 8.40 | 8.12 | 11.56 | |
Capex per Share |
(2.22) | (2.24) | (2.31) | (2.36) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates